
Remdesivir is a broad-spectrum nucleotide analogue and a potent inhibitor of viral RNA-dependent RNA polymerase (RdRp), used in critical virology research.
In the field of advanced antiviral pharmacology, the ability to selectively inhibit viral enzymes without disrupting host cellular functions is a major advantage. Remdesivir is specifically selected because its active triphosphate form competes with ATP for incorporation into nascent RNA chains. For instance, it is used to investigate the suppression of Filoviridae, Paramyxoviridae, and Coronaviridae families. Consequently, it facilitates the development of high-efficacy intravenous antiviral therapies with higher efficiency. As a result, Zyntex ensures that our high-purity API is produced under strict anhydrous conditions to maintain the stability of its phosphoramidate moiety.
Moreover, the research-grade Remdesivir provided by Zyntex is a vital component in the study of viral resistance mutations. This application allows for the creation of advanced genomic mapping profiles, undoubtedly pushing the boundaries of what is possible in modern pandemic mitigation. At the same time, its role as a broad-spectrum inhibitor is highly valued by global biotechnology firms focusing on emerging zoonotic threats. In short, our product serves as a dependable “precision-nucleotide” for companies focusing on both acute viral management and sustainable healthcare infrastructure.
Recently, scientific interest has surged regarding the optimization of Remdesivir delivery systems to improve pulmonary bioavailability. Because of this, Zyntex offers specialized analytical documentation to provide safer and more convenient validation in high-containment laboratory environments. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances chemical potency with rigorous logistical safety. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in fine chemistry or clinical research—achieve the highest levels of purity and yield.
This high-performance antiviral nucleotide is specifically vital in the following four sectors:
A potent agent for studying polymerase inhibition; thus enabling the production of high-value enzymatic activity data.
Key API for parenteral antiviral formulations; consequently vital for developing stable emergency-use medications.
Used in viral plaque reduction neutralization tests (PRNT); undoubtedly essential for quantifying drug efficacy.
Used as a precursor for nucleoside analogue modifications; specifically helping researchers design novel antiviral scaffolds.
| Parameter | Standard Value |
|---|---|
| Product Name | Remdesivir (GS-5734) |
| Assay / Purity | Min. 99.0% (HPLC) |
| Molecular Formula | C27H35N6O8P |
| CAS Number | 1809249-37-3 |
⚠️ Safety Warning: Remdesivir is a potent bio-active agent. Therefore, it must be handled under strict laboratory protocols (BSL-2 or higher depending on the viral agent used) by trained personnel using appropriate PPE. Store at -20°C in an airtight container, protected from light and moisture to prevent chemical degradation.
For comprehensive toxicological profiles, material safety data sheets (MSDS), and physical property validation, please refer to the official PubChem entry: Chemical Safety Data – Remdesivir (1809249-37-3)